Fig. 2: Elevated MSLN is associated with clinical features of TNBC. | Cell Death Discovery

Fig. 2: Elevated MSLN is associated with clinical features of TNBC.

From: MSLN-mediated activation of EGFR-ERK1/2 signaling drives liver metastasis in breast cancer

Fig. 2: Elevated MSLN is associated with clinical features of TNBC.

A Comparison of MSLN expression across human breast cancer subtypes using the UALCAN website. Kaplan–Meier plots illustrated overall survival (B) and distant metastasis-free survival (C) of TNBC patients with high or low MSLN expression. D MSLN expression in clinical primary of TNBC and liver metastases was showed in representative IHC images (Scale bars, 100 μm), and IHC score statistics were carried out (results represent as the mean ± SD). (*P < 0.05, **P < 0.01, ***P < 0.001).

Back to article page